Biomarker detection
Antibodies, ELISA kits and assay reagents for studying EGFR, ALK, KRAS, PD-L1, TP53, Ki-67, VEGF, cytokines and lung tumor-associated markers.
Explore research-use products for lung tumor biology, NSCLC and SCLC studies, oncogenic signaling, immune checkpoint pathways, angiogenesis, metastasis, tumor microenvironment research and biomarker-driven oncology workflows.
Lung cancer research products support studies of tumor initiation, molecular drivers, immune evasion, inflammation, hypoxia, metastasis, drug response and tumor microenvironment interactions.
Antibodies, ELISA kits and assay reagents for studying EGFR, ALK, KRAS, PD-L1, TP53, Ki-67, VEGF, cytokines and lung tumor-associated markers.
Products for lung cancer cell culture, viability, apoptosis, migration, invasion, EMT, hypoxia and drug-response experiments.
Tools for studying oncogenic signaling, immune checkpoints, angiogenesis, DNA damage response, resistance mechanisms and tumor progression.
Organize lung tumor research products by experimental workflow, target class and biological application.
Research antibodies for EGFR, ALK, PD-L1, PD-1, KRAS pathway proteins, TP53, Ki-67, cytokeratins, E-cadherin, vimentin and immune markers.
IHC · WB · IF · FlowQuantitative kits for cytokines, growth factors, inflammatory markers, angiogenesis markers, immune signaling proteins and tumor-associated analytes.
Serum · Plasma · LysateProteins for receptor binding studies, assay development, antibody validation, pathway stimulation and lung tumor biology research.
EGF · VEGF · CytokinesMedia, supplements, matrices, transfection reagents and culture tools for lung cancer cell models, spheroids and experimental workflows.
2D · 3D · SpheroidDNA/RNA extraction, qPCR reagents, controls, primers and workflow tools for EGFR, ALK, KRAS, ROS1, MET, RET, NTRK and expression studies.
qPCR · NGS SupportAssays for cell viability, ATP, caspase activity, cytotoxicity, oxidative stress, proliferation and treatment-response research.
Drug ResponseResearch tools for EMT, wound healing, invasion, extracellular matrix remodeling, metastatic potential and tumor cell motility studies.
EMT · MetastasisPositive controls, calibrators, purified proteins, lysates and validation reagents for reproducible lung cancer research workflows.
QC · ValidationLung cancer research frequently investigates oncogenic drivers, immune checkpoints, proliferation markers, angiogenesis pathways and tumor microenvironment signals.
Used in studies of NSCLC biology, receptor activation, proliferation and pathway signaling.
Relevant to molecular subtype research and kinase pathway activation studies.
Studied in tumor growth, resistance mechanisms, metabolic changes and progression.
Used in immuno-oncology research and tumor immune-evasion studies.
Lung cancer product selection often depends on sample type, assay platform, target biology and experimental endpoint.
Western blot, ELISA, IHC, immunofluorescence and protein quantification workflows.
RNA extraction, qPCR, pathway-expression studies and mutation-focused molecular workflows.
Cell proliferation, apoptosis, viability, migration, invasion and spheroid studies.
Immune checkpoint markers, cytokine analysis, T-cell interaction and inflammation studies.
Lung cancer research products are used across tumor biology, translational oncology, assay development and preclinical research settings.
Products for adenocarcinoma, squamous cell carcinoma, large cell carcinoma and biomarker-driven NSCLC models.
Research tools for neuroendocrine biology, rapid proliferation, DNA damage response and resistance mechanisms.
Tools for studying immune cells, fibroblasts, extracellular matrix, cytokines, hypoxia and angiogenesis.
Products for EMT, invasion, migration, matrix remodeling and metastatic potential studies.
Viability, apoptosis, proliferation and signaling assays for experimental compound-response studies.
Antibodies, proteins, controls and standards for validating target detection and assay reproducibility.
Product selection should be based on target, sample type, platform compatibility, validation data and intended experimental endpoint.
Examples include EGFR, ALK, KRAS, PD-L1, VEGF, TP53, Ki-67, cytokines or EMT markers.
Check whether the product is suitable for ELISA, IHC, WB, IF, flow cytometry, qPCR or cell culture.
Review sample type such as serum, plasma, cell lysate, tissue homogenate, cultured cells or FFPE tissue.
Use appropriate controls, standards and reproducibility criteria for reliable research results.
Lung cancer research products are laboratory-use tools that help scientists study lung tumor biology, biomarkers, signaling pathways, immune response, metastasis and experimental treatment response.
Common product types include antibodies, ELISA kits, recombinant proteins, cell culture reagents, molecular biology tools, cell viability assays, apoptosis assays, controls and standards.
Frequently studied biomarkers include EGFR, ALK, KRAS, ROS1, MET, RET, NTRK, BRAF, HER2, PD-L1, PD-1, TP53, VEGF and Ki-67.
Researchers can browse lung tumor research products through the CancerSpot lung tumor product category.
View Lung Tumor Research ProductsClear answers to common product and research workflow questions.
Lung cancer research products are laboratory-use reagents and assay tools used to study lung tumor biology, biomarkers, signaling pathways, immune response, metastasis, drug response and tumor microenvironment mechanisms.
Common product types include primary antibodies, secondary antibodies, ELISA kits, recombinant proteins, cell culture reagents, qPCR tools, extraction kits, viability assays, apoptosis assays, migration assays and controls.
Commonly studied biomarkers include EGFR, ALK, KRAS, ROS1, MET, RET, NTRK, BRAF, HER2, PD-L1, PD-1, TP53, VEGF and Ki-67.
No. The products described on this page are presented for research use only unless a specific product page clearly states otherwise.
Antibodies are often used for detecting protein expression or localization in methods such as IHC, WB, IF or flow cytometry. ELISA kits are commonly used for quantitative measurement of soluble or extracted analytes in compatible samples.
Authoritative sources supporting lung cancer biology, biomarkers and research context.